Tisagenlecleucel
Modify Date: 2024-04-11 16:52:58
Tisagenlecleucel structure
|
Common Name | Tisagenlecleucel | ||
|---|---|---|---|---|
| CAS Number | 1823078-37-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TisagenlecleucelTisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma[1][2]. |
| Name | Tisagenlecleucel |
|---|
| Description | Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Tisagenlecleucel 靶向并清除表达 CD19 的 B 细胞，显示出对 B 细胞淋巴瘤的疗效[1]。 |
| References |
| No Any Chemical & Physical Properties |